StockDuty ← Dashboard Nov 07, 2026 07:23 PM ET
SignalCorporate

ELI LILLY JUST RAISED ITS 2026 REVENUE FORECAST BY $5.5 BILLION . IS THE STOCK STILL A BUY ?

Eli Lilly raised its 2026 revenue forecast by $5.5 billion.

Eli Lilly raised its 2026 revenue forecast by $5.5 billion.
Eli Lilly raised its 2026 revenue forecast by $5.5 billion. — impact context not separately stored; see What changed.
Sources